All stocks Β· AMWILL
AH

Amwill Health Care Limited

AMWILL BSE Medical Distribution Healthcare

Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India. It offers product formulations for anti-acne, dry skin, anti-agin…

ISIN INE0U2L01017
Listed β€”
Quarters tracked β€”
Filings 8 docs

About

Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India. It offers product formulations for anti-acne, dry skin, anti-aging, anti-fungal, anti-histaminic, anti-perspirant, antibiotics, skin lightening, hair care, steroid and keratolytic, sunscreen, vitiligo, miscellaneous, peri-orbital hyperpigmentation, anti-scar, topical antibiotics, antioxidants, and anti-scabies, as well as cosmeceutical and aesthetic categories. The company was founded in 2009 and is headquartered in Bengaluru, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in β€” check back soon.

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales 43.0037.0042.0028.0026.0017.00
Expenses 30.0026.0025.0024.0022.0018.00
Operating Profit 13.0012.0017.004.004.00-1.00
OPM % 30.0031.0040.0015.0014.00-6.00
Other Income 3.001.000.000.000.000.00
Interest 0.000.000.000.000.000.00
Depreciation 1.000.000.000.000.000.00
Profit before tax 15.0012.0017.004.003.00-1.00
Tax % 26.0010.0025.0025.0023.00-3.00
Net Profit 11.0011.0012.003.003.00-1.00
EPS in Rs 5.715.362,500.001,036.67856.67-333.33
Dividend Payout % 9.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Equity Capital 20.0020.000.050.030.030.03
Reserves 61.0049.0017.005.001.00-1.00
Borrowings 0.000.000.000.000.000.00
Other Liabilities 6.002.002.008.005.009.00
Total Liabilities 87.0071.0019.0012.007.008.00
Fixed Assets 1.001.001.001.000.001.00
CWIP 0.000.001.000.000.000.00
Investments 3.000.000.000.000.000.00
Other Assets 83.0070.0018.0012.006.007.00
Total Assets 87.0071.0019.0012.007.008.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Cash from Operating Activity 8.006.00-3.005.003.000.00
Cash from Investing Activity 6.00-46.00-1.00-1.000.00-1.00
Cash from Financing Activity 0.0041.000.000.000.000.00
Net Cash Flow 14.001.00-4.003.003.00-1.00
Free Cash Flow 7.005.00-4.004.003.00-1.00
CFO/OP % 88.0062.006.00135.00108.00-26.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debtor Days 177.00163.00114.0016.0012.0093.00
Inventory Days β€”β€”66.00β€”β€”β€”
Days Payable β€”β€”39.00β€”β€”β€”
Cash Conversion Cycle 177.00163.00141.0016.0012.0093.00
Working Capital Days 158.00166.00111.00-38.00-25.00-45.00
ROCE % 21.0028.00153.00133.001,069.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Mar 2026 Sep 2025 Mar 2025
Promoters 70.65 70.65 70.65
FIIs 0.00 1.16 1.16
Public 29.35 28.20 28.19
No. of Shareholders 1,483 1,606 1,374

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 07 Aug 2026 08 Aug 2026 β€” 0.50

Announcements

5 filings